InvestorsObserver
×
News Home

Oncolytics Biotech, Inc. (ONCY) Stock: Is It a Good Pick?

Monday, August 17, 2020 11:18 AM | InvestorsObserver Analysts

Mentioned in this article

Oncolytics Biotech, Inc. (ONCY) Stock: Is It a Good Pick?

Oncolytics Biotech, Inc. (ONCY) stock has risen 173.02% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ONCY stock a score of 70 out of a possible 100.

That rank is influenced by a fundamental score of 97. In addition to the average rating from Wall Street analysts, ONCY stock has a mean target price of 7.713. This means analysts expect the stock to gain 348.43% over the next 12 months. ONCY's rank also includes a short-term technical score of 89. The long-term technical score for ONCY is 25.

Overall Score - 70
ONCY has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on ONCY!

What's Happening with ONCY Stock Today

Oncolytics Biotech, Inc. (ONCY) stock has gained 2.69% while the S&P 500 has risen 0.28% as of 11:14 AM on Monday, Aug 17. ONCY has risen $0.05 from the previous closing price of $1.67 on volume of 231,442 shares. Over the past year the S&P 500 is up 15.69% while ONCY has risen 173.02%. ONCY lost -$0.78 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Oncolytics Biotech, Inc. (ONCY) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App